UK trial tests third doses of COVID-19 vaccines
Initial results trialling seven vaccines will inform plans for Autumn booster programme
Read More
Author: Selina McKee
Vectura, Inspira team up to develop inhaled COVID-19 drug
The deal will see Vectura test Inspira’s inhaled IPX formulation candidates
Read More
Imfinzi, tremelimumab combo boosts survival in lung cancer
The POSEIDON trial is the first Phase III study to demonstrate an overall survival benefit with tremelimumab
Read More
Only one week left to enter the Patient Partnership Index 2021
The entry deadline is Friday May 14
Read More
UK launch for progressive multiple sclerosis mega-trial
It is hoped that the multi-armed Octopus trial will rapidly speed up development of new treatments
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
